MDA SPACE LTD (MDA.CA) Stock Fundamental Analysis
Canada - Toronto Stock Exchange - TSX:MDA - CA55293N1096 - Common Stock
24.2 CAD
+0.02 (+0.08%)
Overall MDA gets a fundamental rating of 6 out of 10. We evaluated MDA against 10 industry peers in the Aerospace & Defense industry. MDA has an average financial health and profitability rating. MDA is not priced too expensively while it is growing strongly. Keep and eye on this one!
1. Profitability
1.1 Basic Checks
In the past year MDA was profitable.
MDA had a positive operating cash flow in the past year.
Of the past 5 years MDA 4 years were profitable.
In the past 5 years MDA always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of MDA (3.63%) is better than 90.00% of its industry peers.
Looking at the Return On Equity, with a value of 8.94%, MDA belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
MDA has a Return On Invested Capital of 5.72%. This is in the lower half of the industry: MDA underperforms 60.00% of its industry peers.
MDA had an Average Return On Invested Capital over the past 3 years of 3.99%. This is below the industry average of 8.50%.
The last Return On Invested Capital (5.72%) for MDA is above the 3 year average (3.99%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.63% | ||
| ROE | 8.94% | ||
| ROIC | 5.72% |
ROA(3y)2.27%
ROA(5y)1.16%
ROE(3y)4.65%
ROE(5y)2.1%
ROIC(3y)3.99%
ROIC(5y)N/A
1.3 Margins
MDA's Profit Margin of 8.48% is amongst the best of the industry. MDA outperforms 90.00% of its industry peers.
In the last couple of years the Profit Margin of MDA has grown nicely.
MDA has a worse Operating Margin (10.97%) than 60.00% of its industry peers.
MDA's Operating Margin has improved in the last couple of years.
MDA has a better Gross Margin (24.54%) than 70.00% of its industry peers.
MDA's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.97% | ||
| PM (TTM) | 8.48% | ||
| GM | 24.54% |
OM growth 3Y34.46%
OM growth 5YN/A
PM growth 3Y129.51%
PM growth 5YN/A
GM growth 3Y-9.5%
GM growth 5YN/A
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MDA is destroying value.
MDA has more shares outstanding than it did 1 year ago.
MDA has a better debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 1.58, we must say that MDA is in the distress zone and has some risk of bankruptcy.
With a decent Altman-Z score value of 1.58, MDA is doing good in the industry, outperforming 80.00% of the companies in the same industry.
MDA has a debt to FCF ratio of 0.55. This is a very positive value and a sign of high solvency as it would only need 0.55 years to pay back of all of its debts.
MDA has a Debt to FCF ratio of 0.55. This is amongst the best in the industry. MDA outperforms 100.00% of its industry peers.
MDA has a Debt/Equity ratio of 0.29. This is a healthy value indicating a solid balance between debt and equity.
MDA has a Debt to Equity ratio of 0.29. This is in the better half of the industry: MDA outperforms 80.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.29 | ||
| Debt/FCF | 0.55 | ||
| Altman-Z | 1.58 |
ROIC/WACC0.61
WACC9.33%
2.3 Liquidity
A Current Ratio of 0.86 indicates that MDA may have some problems paying its short term obligations.
MDA has a worse Current ratio (0.86) than 80.00% of its industry peers.
A Quick Ratio of 0.85 indicates that MDA may have some problems paying its short term obligations.
MDA has a better Quick ratio (0.85) than 70.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.86 | ||
| Quick Ratio | 0.85 |
3. Growth
3.1 Past
MDA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 98.25%, which is quite impressive.
The Earnings Per Share has been growing by 185.75% on average over the past years. This is a very strong growth
MDA shows a strong growth in Revenue. In the last year, the Revenue has grown by 33.74%.
The Revenue has been growing by 31.32% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)98.25%
EPS 3Y185.75%
EPS 5YN/A
EPS Q2Q%-16.67%
Revenue 1Y (TTM)33.74%
Revenue growth 3Y31.32%
Revenue growth 5YN/A
Sales Q2Q%45.11%
3.2 Future
The Earnings Per Share is expected to grow by 34.67% on average over the next years. This is a very strong growth
Based on estimates for the next years, MDA will show a very strong growth in Revenue. The Revenue will grow by 23.76% on average per year.
EPS Next Y107.77%
EPS Next 2Y49.97%
EPS Next 3Y34.67%
EPS Next 5YN/A
Revenue Next Year52.07%
Revenue Next 2Y31.15%
Revenue Next 3Y23.76%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 21.42, which indicates a rather expensive current valuation of MDA.
Based on the Price/Earnings ratio, MDA is valued a bit cheaper than the industry average as 70.00% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 26.31. MDA is around the same levels.
The Price/Forward Earnings ratio is 15.37, which indicates a correct valuation of MDA.
The rest of the industry has a similar Price/Forward Earnings ratio as MDA.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.59, MDA is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.42 | ||
| Fwd PE | 15.37 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MDA is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, MDA is valued a bit cheaper than 70.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.31 | ||
| EV/EBITDA | 11.32 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MDA has a very decent profitability rating, which may justify a higher PE ratio.
MDA's earnings are expected to grow with 34.67% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.2
PEG (5Y)N/A
EPS Next 2Y49.97%
EPS Next 3Y34.67%
5. Dividend
5.1 Amount
No dividends for MDA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:MDA (11/28/2025, 7:00:00 PM)
24.2
+0.02 (+0.08%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)
Earnings (Next)
Inst Owners32.56%
Inst Owner ChangeN/A
Ins Owners1.18%
Ins Owner ChangeN/A
Market Cap3.05B
Revenue(TTM)1.08B
Net Income(TTM)114.70M
Analysts78.33
Price Target41.12 (69.92%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)21.62%
Min EPS beat(2)21.08%
Max EPS beat(2)22.16%
EPS beat(4)4
Avg EPS beat(4)29.79%
Min EPS beat(4)19.18%
Max EPS beat(4)56.74%
EPS beat(8)7
Avg EPS beat(8)31.88%
EPS beat(12)11
Avg EPS beat(12)88.39%
EPS beat(16)14
Avg EPS beat(16)87.43%
Revenue beat(2)1
Avg Revenue beat(2)3.32%
Min Revenue beat(2)-0.24%
Max Revenue beat(2)6.87%
Revenue beat(4)3
Avg Revenue beat(4)3.78%
Min Revenue beat(4)-0.24%
Max Revenue beat(4)7.65%
Revenue beat(8)5
Avg Revenue beat(8)3.09%
Revenue beat(12)9
Avg Revenue beat(12)2.82%
Revenue beat(16)10
Avg Revenue beat(16)0.84%
PT rev (1m)-6.09%
PT rev (3m)-21.61%
EPS NQ rev (1m)-0.99%
EPS NQ rev (3m)-5.24%
EPS NY rev (1m)-1.23%
EPS NY rev (3m)-2.04%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.09%
Revenue NY rev (1m)-0.12%
Revenue NY rev (3m)-0.86%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.42 | ||
| Fwd PE | 15.37 | ||
| P/S | 2.25 | ||
| P/FCF | 4.31 | ||
| P/OCF | 3.17 | ||
| P/B | 2.38 | ||
| P/tB | 12.02 | ||
| EV/EBITDA | 11.32 |
EPS(TTM)1.13
EY4.67%
EPS(NY)1.57
Fwd EY6.51%
FCF(TTM)5.62
FCFY23.22%
OCF(TTM)7.63
OCFY31.52%
SpS10.73
BVpS10.17
TBVpS2.01
PEG (NY)0.2
PEG (5Y)N/A
Graham Number16.08
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.63% | ||
| ROE | 8.94% | ||
| ROCE | 7.95% | ||
| ROIC | 5.72% | ||
| ROICexc | 8.9% | ||
| ROICexgc | 61.78% | ||
| OM | 10.97% | ||
| PM (TTM) | 8.48% | ||
| GM | 24.54% | ||
| FCFM | 52.35% |
ROA(3y)2.27%
ROA(5y)1.16%
ROE(3y)4.65%
ROE(5y)2.1%
ROIC(3y)3.99%
ROIC(5y)N/A
ROICexc(3y)4.25%
ROICexc(5y)N/A
ROICexgc(3y)14.8%
ROICexgc(5y)N/A
ROCE(3y)5.54%
ROCE(5y)N/A
ROICexgc growth 3Y59.28%
ROICexgc growth 5YN/A
ROICexc growth 3Y71.38%
ROICexc growth 5YN/A
OM growth 3Y34.46%
OM growth 5YN/A
PM growth 3Y129.51%
PM growth 5YN/A
GM growth 3Y-9.5%
GM growth 5YN/A
F-Score6
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.29 | ||
| Debt/FCF | 0.55 | ||
| Debt/EBITDA | 1.52 | ||
| Cap/Depr | 262.11% | ||
| Cap/Sales | 18.71% | ||
| Interest Coverage | 8.48 | ||
| Cash Conversion | 392.53% | ||
| Profit Quality | 617.7% | ||
| Current Ratio | 0.86 | ||
| Quick Ratio | 0.85 | ||
| Altman-Z | 1.58 |
F-Score6
WACC9.33%
ROIC/WACC0.61
Cap/Depr(3y)234.8%
Cap/Depr(5y)169.15%
Cap/Sales(3y)23.53%
Cap/Sales(5y)18.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.25%
EPS 3Y185.75%
EPS 5YN/A
EPS Q2Q%-16.67%
EPS Next Y107.77%
EPS Next 2Y49.97%
EPS Next 3Y34.67%
EPS Next 5YN/A
Revenue 1Y (TTM)33.74%
Revenue growth 3Y31.32%
Revenue growth 5YN/A
Sales Q2Q%45.11%
Revenue Next Year52.07%
Revenue Next 2Y31.15%
Revenue Next 3Y23.76%
Revenue Next 5YN/A
EBIT growth 1Y115.07%
EBIT growth 3Y76.57%
EBIT growth 5YN/A
EBIT Next Year179.33%
EBIT Next 3Y51.75%
EBIT Next 5YN/A
FCF growth 1Y1778.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y628.56%
OCF growth 3Y124.48%
OCF growth 5YN/A
MDA SPACE LTD / MDA.CA FAQ
What is the fundamental rating for MDA stock?
ChartMill assigns a fundamental rating of 6 / 10 to MDA.CA.
What is the valuation status for MDA stock?
ChartMill assigns a valuation rating of 6 / 10 to MDA SPACE LTD (MDA.CA). This can be considered as Fairly Valued.
What is the profitability of MDA stock?
MDA SPACE LTD (MDA.CA) has a profitability rating of 6 / 10.
What is the valuation of MDA SPACE LTD based on its PE and PB ratios?
The Price/Earnings (PE) ratio for MDA SPACE LTD (MDA.CA) is 21.42 and the Price/Book (PB) ratio is 2.38.